Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI

Summary

This randomized, open label, controlled, parallel group study is designed to test whether 2-day high dose atorvastatin administration before PCI and 30-day continuous intensive atorvastatin treatment is superior to usual care, in terms of peri-PCI cardiovascular events, as well as 6-month prognosis. The goal is to set up an optimized protocol for peri-PCI statin treatment in Chinese CHD patients. Safety will also be observed.

Timeline

Start

2010-06

Primary completion

2011-10

Completion

2011-10

Drugs

Indications